TABLE 1—

Randomised, double-blind, placebo-controlled studies with OM-85 in paediatric patients prone to respiratory tract infections

Reference	Year	Country	Study population
Reference	Year	Country	Age range yrs	No OM-85	No placebo
Schaad [16]	2002	Switzerland/Germany	3–8	120	100
Jara-Pérez [17]	2000	Mexico	6–13	99	100
Gutiérrez-Tarango [18]	2001	Mexico	1–12	26	28
Collet [19]	1993	France	0.5–2	210	213
Paupe [20]	1991	France	0.5–19	61	55